These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3316555)

  • 41. [Management of rejection following heart transplantation using oral steroid medication].
    Wahlers T; Frimpong K; Schäfers HJ; Fieguth HJ; Jurmann M; Herrmann G; Kemnitz J; Haverich A
    Dtsch Med Wochenschr; 1987 Nov; 112(47):1816-8. PubMed ID: 3315549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of rejection in heart transplant recipients: does moderate rejection always require treatment?
    Hutter JA; Wallwork J; English TA
    J Heart Transplant; 1990; 9(2):87-91. PubMed ID: 2319377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infection as a complication of heart transplantation.
    Linder J
    J Heart Transplant; 1988; 7(5):390-4. PubMed ID: 3058911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes and heart transplantation.
    Rhenman MJ; Rhenman B; Icenogle T; Christensen R; Copeland J
    J Heart Transplant; 1988; 7(5):356-8. PubMed ID: 3058905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
    De Maria R; Minoli L; Parolini M; Gavazzeni G; Gentile M; Grossi P; Livi U; Parisi F; Utili R
    J Heart Lung Transplant; 1996 Feb; 15(2):124-35. PubMed ID: 8672515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Powerful but limited immunosuppression for cardiac transplantation with cyclosporins and low-dose steroid.
    Griffith BP; Hardesty RL; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):35-42. PubMed ID: 6361393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
    Wagoner LE; Taylor DO; Olsen SL; Bristow MR; O'Connell JB; Hammond EH; Lappe DL; Renlund DG
    Clin Transplant; 1996 Oct; 10(5):437-43. PubMed ID: 8930458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
    Nohria A; Ehtisham J; Ramahi TM
    J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of moderate heart allograft rejection with cyclosporine.
    Radovancevic B; Frazier OH
    J Heart Transplant; 1986; 5(4):307-11. PubMed ID: 3114444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterotopic heart transplantation in 1988--recent selective indications and outcome.
    Reichenspurner H; Hildebrandt A; Boehm D; Kaulbach HG; Willems S; Odell JA; Horak A; Reichart B
    J Heart Transplant; 1989; 8(5):381-6. PubMed ID: 2795280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reevaluation of steroid tapering after steroid pulse therapy for heart rejection.
    Lonquist JL; Radovancevic B; Vega JD; Burnett CM; Birovljev S; Saade NG; Duncan JM; Frazier OH
    J Heart Lung Transplant; 1992; 11(5):913-9. PubMed ID: 1420239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation.
    Grossi P; De Maria R; Caroli A; Zaina MS; Minoli L
    J Heart Lung Transplant; 1992; 11(5):847-66. PubMed ID: 1420232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastrointestinal complications in heart and in heart-lung transplant patients.
    Augustine SM; Yeo CJ; Buchman TG; Achuff SC; Baumgartner WA
    J Heart Lung Transplant; 1991; 10(4):547-55; discussion 55-6. PubMed ID: 1911797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and severity of acute cardiac allograft rejection with two different low-dose cyclosporine maintenance protocols.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Kober I; Wolner E
    Ann Thorac Surg; 1988 Oct; 46(4):382-8. PubMed ID: 3052335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paediatric cardiac transplantation with steroid-sparing maintenance immunosuppression.
    Au J; Gregory JW; Colquhoun IW; Scott CD; Hilton CJ; Hunter S; Dark JH
    Arch Dis Child; 1992 Oct; 67(10):1262-6. PubMed ID: 1444525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of cyclosporine on the transplanted human heart.
    Stovin PG; English TA
    J Heart Transplant; 1987; 6(3):180-5. PubMed ID: 3309222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac transplantation with corticosteroid-free immunosuppression: long-term results.
    Lee KF; Pierce JD; Hess ML; Hastillo AK; Wechsler AS; Guerraty AJ
    Ann Thorac Surg; 1991 Aug; 52(2):211-7; discussion 218. PubMed ID: 1863141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac transplant patient at one year. Cyclosporine vs conventional immunosuppression.
    Emery RW; Cork R; Christensen R; Levinson MM; Icenogle TB; Riley J; Ott RA; Copeland JG
    Chest; 1986 Jul; 90(1):29-33. PubMed ID: 3522120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of acute preoperative pulmonary infarction on the results of heart transplantation.
    Young JN; Yazbeck J; Esposito G; Mankad P; Townsend E; Yacoub M
    J Heart Transplant; 1986; 5(1):20-2. PubMed ID: 3302155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.